Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells.
Dr. Opoku, Yeboah Kwaku
Lecturer
0553960777 | |
ykopoku@uew.edu.gh |
Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells.
Publication Year
2020
Article Title
Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells.
Journal
EXCLI Journal
Volume
19
Page Numbers
567-581